D-0565-2024 Class II Ongoing

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
July 3, 2024
Initiation Date
May 20, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
220,400 cartridges

Product Description

Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24

Reason for Recall

Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Distribution Pattern

US Nationwide and Puerto Rico.

Code Information

Lot#: HJ7566; Exp 2025/05 Lot#: HN8747; Exp 2025/09 Lot#: HN8749; Exp 2025/09